Grants per year
Personal profile
Research Interests
Dr. Siziopikou's subspecialty focus is on breast tumor markers and molecular diagnostics in breast cancer. Her research interests center around molecular markers of prognostic and predictive significance in breast cancer.
Certifications and Licenses
| Anatomic Pathology |
Training Experience
| 1994 | Residency, Beth Israel Deaconess Medical Center, Boston |
| 1995 | Fellowship, Beth Israel Deaconess Medical Center, Boston |
Education/Academic qualification
PhD, Rush Medical Collage
… → 1990
MD, Aristotle University of Thessaloniki
… → 1985
Research interests
- Breast Cancer
- Breast Disease
- Cancer Biology
- Pathology
Fingerprint
Dive into the research topics where Kalliopi P Siziopikou is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants
- 1 Finished
-
Investigating the mechanisms of CD44s splice isoform in breast cancer metastasis
Cheng, C., Cheng, S. & Siziopikou, K. P.
2/4/14 → 5/31/16
Project: Research project
Research Output
-
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials
International Immuno-Oncology Biomarker Working Group, Dec 1 2020, In: npj Breast Cancer. 6, 1, 15.Research output: Contribution to journal › Review article › peer-review
Open Access2 Scopus citations -
Landscape of circulating tumour DNA in metastatic breast cancer
Davis, A. A., Jacob, S., Gerratana, L., Shah, A. N., Wehbe, F., Katam, N., Zhang, Q., Flaum, L., Siziopikou, K. P., Platanias, L. C., Gradishar, W. J., Behdad, A. & Cristofanilli, M., Aug 2020, In: EBioMedicine. 58, 102914.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer
the International Immuno-Oncology Biomarker Working Group, Dec 1 2020, In: npj Breast Cancer. 6, 1, 17.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice
Gonzalez-Ericsson, P. I., Stovgaard, E. S., Sua, L. F., Reisenbichler, E., Kos, Z., Carter, J. M., Michiels, S., Le Quesne, J., Nielsen, T. O., Lænkholm, A. V., Fox, S. B., Adam, J., Bartlett, J. M. S., Rimm, D. L., Quinn, C., Peeters, D., Dieci, M. V., Vincent-Salomon, A., Cree, I., Hida, A. I. & 55 others, , Apr 1 2020, In: Journal of Pathology. 250, 5, p. 667-684 18 p.Research output: Contribution to journal › Review article › peer-review
Open Access14 Scopus citations -
The PD-1/PD-L1 Axis in HER2+ Ductal Carcinoma In Situ (DCIS) of the Breast
Ubago, J. M., Blanco, L. Z., Shen, T. & Siziopikou, K. P., Jul 5 2019, In: American journal of clinical pathology. 152, 2, p. 169-176 8 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations